Table 1.
Serum marker | Control | Treated | p-value* |
---|---|---|---|
Creatine kinase (U/L) | 648 ± 229 | 419 ±88 | 0.39 |
AST(U/L) | 280 ± 84 | 248 ± 81 | 0.79 |
ALT(U/L) | 142 ± 61 | 110 ± 44 | 0.69 |
ALP (U/L) | 85 ± 15 | 75 ± 8 | 0.55 |
GGT (U/L) | < 3 | < 3 | |
GLDH (U/L) | 73 ± 46 | 103 ± 43 | 0.66 |
Amylase(U/L)^ | 1365 ± 748 | 1344 ± 554 | 0.77 |
Total bilirubin (mg/dL) | 0.18 ± 0.03 | 0.18 ± 0.03 | >0.99 |
BUN (mg/dL) | 23 ± 2 | 43 ± 12 | 0.17 |
Glucose (mg/dL) | 194 ± 23 | 173 ± 10 | 0.43 |
Cholesterol (mg/dL) | 81 ± 3 | 94 ± 12 | 0.36 |
Total protein (g/dL) | 4.4 ± 0.2 | 4.4 ± 0.1 | 0.91 |
Albumin (g/dL) | 2.4 ± 0.063 | 2.4 ± 0.048 | 0.25 |
Globulin (g/dL) | 1.9 ± 0.2 | 2.2 ± 0.075 | 0.29 |
Calcium (mg/dL) | 8.7 ± 0.3 | 8.7 ± 0.2 | 0.94 |
Phosphorous (mg/dL) | 6.7 ± 0.8 | 5.6 ± 0.5 | 0.29 |
Sodium (mEq/L) | 147.5 ± 1.7 | 153.8 ± 2.8 | 0.10 |
Potassium (mEq/L) | 5.6 ± 0.5 | 5.0 ± 0.2 | 0.30 |
Chloride (mEq/L) | 114.5 ± 1.1 | 119.5 ± 2.4 | 0.10 |
Data represent mean ± SEM; n=4/group
, p > 0.05; no significant difference
, elevated levels in both cohorts suggesting age-related dysfunctions